Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Buprenorphine and Integrated HIV Care Evaluation
This study is currently recruiting participants.
Study NCT00124358. Last updated on March 23, 2007.
Information provided by The New York Academy of Medicine
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Opioid-Related Disorders
HIV Infections
AIDS
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
Infection
More general conditions related to this trial
Disorders of Environmental Origin
Immune System Diseases
Immunologic Deficiency Syndromes
Lentivirus Infections
Mental Disorders
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Substance-Related Disorders
Virus Diseases
Interventions listed in this trial
Buprenorphine
Additional drug interventions recognized in this trial
Analgesics, Opioid
More general drug interventions related to this trial
Analgesics
Central Nervous System Agents
Central Nervous System Depressants
Narcotic Antagonists
Narcotics
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
The New York Academy of Medicine
Health Resources &Services Administration
El Rio Santa Cruz Neighborhood Health Center
Organization to Achieve Solutions in Substance Abuse (OASIS)
Oregon Health and Science University
Montefiore Medical Center
University of Miami
Brown University
University of California, San Francisco
Johns Hopkins University
CORE Center, Cook County Bureau of Health Services
Yale University
Back to top of Main Content